Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. This is important due to the UK’s currently limited short-scale manufacturing capacity.

Communication 105

Communication 105

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. Topic sponsors are not involved in the creation of editorial content. This construction is planned to create over 150 highly skilled jobs.

Vaccines 140

Vaccines Communication 140

Pharmaceutical Technology

FEBRUARY 8, 2023

Genenta Science and AGC Biologics have signed a development and manufacturing service agreement (MSA). Under the deal, AGC Biologics will be responsible for manufacturing the cell therapy lentivirus-based product for the ongoing clinical programmes of Genenta Science.

Immunity 52

Immunity Immunization 52

Pharmaceutical Technology

JUNE 29, 2022

Terumo Blood and Cell Technologies and BioBridge Global subsidiary, GenCure, have entered a new partnership agreement to expand and integrate cell and gene therapy manufacturing solutions. In the initial stage, the alliance will use Terumo and GenCure’s capabilities to set up a reference manufacturing centre for BioBridge.

105

105

Express Pharma

FEBRUARY 8, 2024

Agilent India has been honoured with the Best Bioprocessing Supplier Award: Analytical Services at the Biopharma Excellence Awards (BEA) 2024. Beyond product offerings, Agilent also provides specialized services to laboratories, enabling them to gain actionable insights, which improve lab performance, safety, compliance, and efficiency.

Research Laboratories 96

Research Laboratories Vaccines 96

Express Pharma

APRIL 20, 2023

Continuous manufacturing The topic of continuous manufacturing is also discussed in frames of PHARMAP 2023. The pharma industry stands out from many other manufacturing industries that have been using the continuous manufacturing technique for decades. I think there are various different ways of development.

Packaging 52

Packaging Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 8, 2023

Global science and technology innovator Danaher has entered a strategic collaboration with the University of Pennsylvania for cellular immunotherapies to address manufacturing challenges impacting cell therapy uptake. The new technologies will also overcome the manufacturing bottlenecks in delivering advanced engineered cell products.

Communication 97

Communication 97

Drug Channels

OCTOBER 5, 2023

Department of Health and Human Services rule allowing non-grandfathered individual and group plans to exclude manufacturers' copay assistance from deductibles. I then follow the dollar to show how they impact plan, patient, and manufacturer costs when compared with traditional approaches to copay support.

Diabetes 78

Diabetes 78

Fuld & Company Blog

AUGUST 10, 2023

In a highly competitive market, staying ahead of customer expectations is critical for any manufacturer. A leading US plumbing fixture manufacturer wanted to develop a groundbreaking shower filter capable of filtering and revitalizing water. Key Learnings : The analysis uncovered essential learnings for the innovation team.

Customer Service 52

Customer Service 52

Safe Biologics

NOVEMBER 12, 2023

On November 6, 2023, the Centers for Medicare and Medicaid Services (CMS) announced a proposed Rule that would permit Medicare Part D plan sponsors to substitute non-interchangeable biosimilars in place of the biologic medicines now used to treat many chronic conditions such as rheumatoid arthritis, Crohn’s disease and cancer.

Biosimilars 113

Biosimilars 113

European Pharmaceutical Review

MARCH 5, 2024

International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. The analytica conference addresses this topic with a session on the applications of AI algorithms in laboratory medicine. Top topics at the trade fair include digitalisation, Laboratory 4.0,

Labelling 85

Labelling 85

Pharmaceutical Technology

DECEMBER 8, 2022

Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. Regulators in Japan have granted approval for the manufacturing plant of Kite in El Segundo, California, US, to produce Yescarta for the Japanese market. Free Whitepaper.

Communication 122

Communication Immunity Immunization Hospitals 122

pharmaphorum

NOVEMBER 30, 2021

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. Pharmaceutical Manufacturing & Packaging Congress provides a networking platform for decision-makers from the pharmaceutical industry to share cases and brand-new solutions in one place.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 14, 2022

Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications. This platform will aid Synplogen in boosting the speed of clinical manufacturing while lowering process development duration and expenses. Free Whitepaper.

Communication 52

Communication 52

Drug Channels

JUNE 5, 2023

thINc’s Specialty Networks and Patient Support Services Summit In-Person Event | August 29-30, 2023 Lowes Philadelphia, Philadelphia, PA www.thinc360.com/specialty Sponsored guest posts are bylined articles that are screened by Drug Channels to ensure a topical relevance to our exclusive audience. Register Today!

Specialty Pharmacies 56

Specialty Pharmacies Biosimilars 56

Drug Channels

MAY 9, 2022

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hub providers and more for unrivaled collaboration to leverage innovation and optimize access. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy.

Specialty Pharmacies 71

Specialty Pharmacies 71

Pharmaceutical Technology

AUGUST 17, 2022

Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. It will also have the potential to scale to Phase III clinical development and commercial manufacturing.

Vaccines 52

Vaccines Drug Development 52

pharmaphorum

NOVEMBER 29, 2021

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies.

Pharmaceutical Manufacturing 70

Pharmaceutical Manufacturing Packaging Pharmaceutical Companies Pharmaceutical Companies 70

PharmaTech

SEPTEMBER 19, 2022

fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing, and fill/finish cGMP manufacturing for sterile injectable and topical products – all under one roof. Discovery the industry's best kept secret.a

Drug Development 40

Drug Development 40

Pharmaceutical Technology

AUGUST 22, 2022

Porton Advanced Solutions has raised $80m in a Series B funding round to expand its end-to-end gene and cell therapy (GCT) contract development and manufacturing organisation (CDMO) platforms. By the end of this year or earlier next year, Porton will have a PD, AD and GMP manufacturing facility spread over more than 200,000ft² for GCT. .

52

52

Pharmaceutical Technology

NOVEMBER 29, 2022

AstraZeneca Oncology R&D executive vice-president Susan Galbraith said: “This acquisition represents a unique opportunity to bring innovative science and leading experts in T-cell receptor biology and cell therapy manufacturing together with our internal oncology cell therapy team, unlocking new ways to target cancer. Free Whitepaper.

Communication 111

Communication 111

Pharmaceutical Technology

MARCH 3, 2023

With over 18 years of experience, Alexander Dragitsch is a commercial customer service contract manufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. The Halle customer service team is a “one-stop-shop” for client requests when it comes to commercial drug product manufacturing,” explains Dragitsch. “The

Customer Service 52

Customer Service Documentation 52

PharmaTech

AUGUST 31, 2022

fast-growing, end-to-end CDMO service provider in Nashville, TN that offers development, testing and fill/finish cGMP manufacturing for sterile injectable and topical products. Here what over 300 decision makers had to say about post-Covid trends - and also the discovery of the industry's best kept secret.a

Vaccines 40

Vaccines 40

Pharmaceutical Technology

DECEMBER 12, 2022

The alliance will utilise the capabilities of both firms, including international cell therapy leadership and manufacturing of Kite. Kite will carry out the manufacturing following the technical transfer. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Communication 105

Communication 105

Pharmaceutical Technology

APRIL 17, 2023

Australian pharmaceutical company Incannex has appointed Quest Pharmaceutical Services (QPS) to advance CannQuit-N (Nicotine), CannQuit-O (Opioid) and Renecann Products in the USA and the European Union (EU). QPS was established in 1995 to provide bioanalytical LC-MS/MS contract services.

Immunity 52

Immunity Immunization Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 8, 2023

GenScript ProBio has collaborated with the New York Blood Center Enterprises’ business unit, called Comprehensive Cell Solutions (CCS), to accelerate the development and manufacture of cell and gene therapies. Topic sponsors are not involved in the creation of editorial content.

Vaccines 52

Vaccines Drug Development Immunity Immunization 52

Pharmaceutical Technology

MARCH 27, 2023

It intends to use a part of the financing to implement innovative manufacturing platforms and technologies which help in increasing the vaccine supply speed, strengthening the domestic supply chain, and reducing cost. Topic sponsors are not involved in the creation of editorial content.

Vaccines 52

Vaccines Communication 52

Pharmaceutical Technology

MAY 2, 2023

Marker Therapeutics has reached a non-dilutive agreement to sell cell manufacturing assets to CellReady for $19m in cash. CellReady is a newly created contract development and manufacturing organisation (CDMO) founded by Marker board member and co-founder John Wilson. Both firms expect to complete the deal on 26 June 2023.

52

52

Pharmaceutical Technology

APRIL 25, 2023

Forge Biologics has received a qualified person (QP) declaration to manufacture adeno-associated virus (AAV) gene therapies to support European clinical programmes. The company stated that a European QP has completed an in-depth audit at its manufacturing facility in Columbus, Ohio, US.

52

52

European Pharmaceutical Review

OCTOBER 5, 2023

Ahead of her presentation on the future of biomanufacturing at CPHI Barcelona, Sheila Ann Mikhail, the co-founder and former CEO of AskBio, engages in a conversation about gene therapy, artificial intelligence, and the importance of being a well-informed innovator when selecting a manufacturing partner.

Immunity 82

Immunity Immunization 82

Pharmaceutical Technology

JANUARY 12, 2023

The collaboration will use the vector biology, manufacturing capabilities and the drug development experience of Solid Biosciences and Phlox Therapeutics’ knowledge in genetic cardiomyopathies and RNA therapies. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Communication 52

Communication Drug Development 52

Pharmaceutical Technology

JANUARY 20, 2023

Increasing manufacturing capacity for pandemic prevention “The other piece we are working on is … how do we build manufacturing capacity around the world?”, The biotech has also made plans to expand manufacturing capacity elsewhere. The manufacturing expansion plans go beyond Covid-19 vaccines and therapeutics. “We

Vaccines 98

Vaccines Communication 98

Pharmaceutical Technology

MARCH 1, 2023

Vertex will also handle all subsequent development, manufacturing, and commercialisation activities. By combining Tevard’s ability to restore the production of critical proteins with Vertex’s clinical, regulatory, and manufacturing expertise, we hope to make an important difference for patients and their families.”

Communication 52

Communication 52

Proxsys Rx

DECEMBER 11, 2023

At the same time, it’s no secret that, since the advent of 340B ESP in 2020, the drug manufacturers have imposed a raft of restrictions on 340B program savings that exist far outside the letter of the law as written by Congress in 1992. We’ve expressed our own strong opinions on the topic in several blog posts, including this one.

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Compounding 52

Drug Channels

SEPTEMBER 21, 2020

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Arquette, R.Ph., REGISTER TODAY.

Specialty Pharmacies 52

Specialty Pharmacies 52

Pharmaceutical Technology

MAY 12, 2023

It works with NYBC’s researchers, manufacturing teams and operations staffs. NYBC Ventures provides companies more than capital, offering access to world-renowned researchers and their labs, cell manufacturing capacity and source materials.” Topic sponsors are not involved in the creation of editorial content.

52

52

Proxsys Rx

MARCH 1, 2024

At the same time, it’s no secret that, since the advent of 340B ESP in 2020, the drug manufacturers have imposed a raft of restrictions on 340B program savings that exist far outside the letter of the law as written by Congress in 1992. We’ve expressed our own strong opinions on the topic in several blog posts, including this one.

Specialty Pharmacies 40

Specialty Pharmacies Hospitals Drug Pricing Compounding 40